| |
NEURONTIN
CASE EVALUATION
Please
fill out the form below to have your case evaluated.
Neurontin
(generic name: gabapentin) may be linked to suicide and suicide
attempt.
Neurontin is prescribed for epilepsy but has been prescribed
for numerous off label uses.
About
Neurontin:
Neurontin was approved for sale in the mid-1990s as a treatment
for epileptic seizures. However it is believed that approximately
80 percent of all Neurontin prescriptions were filled for
unapproved medical conditions. Neurontin is also believed
to be linked to suicidal behavior.
It is believed
that Parke-Davis which was acquired by Pfizer in 2000 had
a systematic strategy to market and promote Neurontin for
untested uses, such as chronic pain, bipolar disorder and
migraine. It is not illegal for a doctor to prescribe a drug
for unapproved conditions, however it is illegal for a drug
company to market a medication for unapproved uses.
In July 2003, Dateline
broadcasted an investigation which accused Parke-Davis of
deliberately falsifying medical information about Neurontin
so doctors would prescribe the drug to treat "off-label"
conditions. State and Federal prosecutors have launched investigations
into the allegedly illegal marketing of Neurontin.
In its year-long
investigation, Dateline interviewed a former Parke-Davis scientist
who alleges company officials encouraged him to persuade physicians
to prescribe Neurontin for a number of disorders, including
attention deficit disorder and bipolar disease, even though
there was minimal preliminary data indicating that Neurontin
could help patients with those diseases.
In May 2003, The
US attorney's office in Boston said in court documents that
the drug company Parke-Davis, now Pfizer, gave illegal kickbacks
to doctors, including trips to Puerto Rico and tickets to
the 1996 Summer Olympics, to prescribe what has become the
nation's best-selling anticonvulsant, Neurontin.
Below
is a list of the unapproved conditions that Neurontin was
marketed to treat:
The 11 illegally
promoted unapproved uses for Neurontin are:
- Bipolar
Disorder
- Pain Syndromes, Peripheral Neuropathy,
and Diabetic Neuropathy
- Treatment of Epilepsy alone (as
monotherapy)
- Reflex Sympathetic Dystrophy (RSD)
- Attention Deficit Disorder (ADD)
- Restless Leg Syndrome (RLS)
- Trigeminal Neuralgia
- Post-Hepatic Neuralgia (PHN)
- Essential Tremor Periodic Limb Movement
- Migraine
- Drug and Alcohol Withdrawal Seizures
Our attorneys are
carefully evaluating all Neurontin suicide and suicidal attempt
side effects cases.
The transmission of this e-mail does not create an attorney-client relationship
between the sender and Kalfus & Nachman. See Disclaimer
Call Kalfus &
Nachman at 1-888-HURTLINE For your free legal
consultation or save time with this online Contact Form. |
|